Trials / Completed
CompletedNCT03525847
The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Professor Dr. Seicean Andrada · Academic / Other
- Sex
- All
- Age
- 18 Years – 86 Years
- Healthy volunteers
- Not accepted
Summary
A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy
Detailed description
A prospective study that compares the results using FNA contrast echoendoscopy versus standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Endosonography | Puncture of the pancreatic solid mass with fine needle aspiration under endoscopic ultrasonographic control. Passage in the same pancreatic mass of first using standard FNA method then contrast enhanced FNA method or vice versa according to the randomization |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2019-01-01
- Completion
- 2020-01-01
- First posted
- 2018-05-16
- Last updated
- 2022-08-25
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT03525847. Inclusion in this directory is not an endorsement.